ZDHHC13
Palmitoyltransferase ZDHHC13
Also known as: FLJ10852, FLJ10941, HIP14L, ZDH13_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUH4
- Gene
- ZDHHC13
- Ensembl
- ENSG00000177054
- Chromosome
- 11
- Canonical length
- 622 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
Predicted to enable magnesium ion transmembrane transporter activity and palmitoyltransferase activity. Involved in positive regulation of canonical NF-kappaB signal transduction. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
622 residues, UniProt reviewed canonical sequence.
>Q8IUH4|ZDHHC13
1 MEGPGLGSQC RNHSHGPHPP GFGRYGICAH ENKELANARE ALPLIEDSSN CDIVKATQYG
61 IFERCKELVE AGYDVRQPDK ENVSLLHWAA INNRLDLVKF YISKGAVVDQ LGGDLNSTPL
121 HWAIRQGHLP MVILLLQHGA DPTLIDGEGF SSIHLAVLFQ HMPIIAYLIS KGQSVNMTDV
181 NGQTPLMLSA HKVIGPEPTG FLLKFNPSLN VVDKIHQNTP LHWAVAAGNV NAVDKLLEAG
241 SSLDIQNVKG ETPLDMALQN KNQLIIHMLK TEAKMRANQK FRLWRWLQKC ELFLLLMLSV
301 ITMWAIGYIL DFNSDSWLLK GCLLVTLFFL TSLFPRFLVG YKNLVYLPTA FLLSSVFWIF
361 MTWFILFFPD LAGAPFYFSF IFSIVAFLYF FYKTWATDPG FTKASEEEKK VNIITLAETG
421 SLDFRTFCTS CLIRKPLRSL HCHVCNCCVA RYDQHCLWTG RCIGFGNHHY YIFFLFFLSM
481 VCGWIIYGSF IYLSSHCATT FKEDGLWTYL NQIVACSPWV LYILMLATFH FSWSTFLLLN
541 QLFQIAFLGL TSHERISLQK QSKHMKQTLS LRKTPYNLGF MQNLADFFQC GCFGLVKPCV
601 VDWTSQYTMV FHPAREKVLR SVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZDHHC13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 36 nTPM
- tonsil: 21 nTPM
- urinary bladder: 21 nTPM
- skin: 18 nTPM
- stomach: 17 nTPM
- rectum: 17 nTPM
Single-cell type
- esophageal apical cells: 488 nCPM
- early spermatids: 189 nCPM
- neutrophil progenitors: 172 nCPM
- prostatic hillock cells: 142 nCPM
- pituitary stem cells: 110 nCPM
- müller glia: 102 nCPM
Immune cell
- eosinophil: 33 nTPM
- basophil: 12 nTPM
- memory CD8 T-cell: 9.6 nTPM
- T-reg: 9.4 nTPM
- memory B-cell: 8.8 nTPM
- gdT-cell: 8.5 nTPM
Brain region
- choroid plexus: 9.2 nTPM
- cerebellum: 8.9 nTPM
- pons: 7.1 nTPM
- hypothalamus: 7 nTPM
- cerebral cortex: 6.3 nTPM
- medulla oblongata: 6.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- magnesium ion transmembrane transporter activity
- palmitoyltransferase activity
- protein-cysteine S-palmitoyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZDHHC13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZDHHC13 as an antibody target. Whether an autoantibody or antibody against ZDHHC13 could matter depends on whether native ZDHHC13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZDHHC13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZDHHC13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...